Skip to main content

Advertisement

Log in

Treatment of bacterial meningitis

  • Review
  • Published:
European Journal of Clinical Microbiology Aims and scope Submit manuscript

Abstract

Bacterial meningitis remains a life-threatening infection at any age, and prompt, adequate treatment is of great prognostic importance. Due to the special features of the meninges as a site of infection, many problems are associated with antimicrobial therapy. Approximately 80 % of the patients with bacterial meningitis belong to the pediatric age group, and the three principal pathogens are Haemophilus influenzae type b,Neisseria meningitidis and Streptococcus pneumoniae.The diagnostic requirements essential for satisfactory management are defined and the antibiotic therapy of meningitis is discussed in detail. Data obtained from both experimental and clinical meningitis are indicative that a minimum bactericidal titre of 1∶10 should be achieved in the cerebrospinal fluid for optimal therapeutic results. Recommendations are given for specific antimicrobial treatment according to patient's age and causative organism, as well as guidelines for further lumbar punctures, duration of therapy and prophylaxis, with emphasis on the important role of the newer cephalosporin compounds in the treatment of meningitis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Schaad, U. B.: Antibiotikatherapie der bakteriellen Meningitis. Therapeutische Umschau 1984, 41: 335–341.

    PubMed  Google Scholar 

  2. McCracken, G. H., Jr.: Management of bacterial meningitis; current status and future prospects. American Journal of Medicine 1984, 74: 215–223.

    Article  Google Scholar 

  3. Scheid, W. M.: Theoretical and practical considerations of antibiotic therapy for bacterial meningitis. Pediatric Infectious Disease 1985, 4: 74–83.

    PubMed  Google Scholar 

  4. Simberkoff, M. S., Moldover, N. H., Rahal, J. J.: Absence of detectable bactericidal and opsonic activities in normal and infected human cerebrospinal fluids. Journal of Laboratory and Clinical Medicine 1980, 95: 362–372.

    PubMed  Google Scholar 

  5. Zwahlen, A., Nydegger, U. E., Vaudaux, P., Lambert, P.-H., Waldvogel, F. A.: Complement-mediated opsonic activity in normal and infected human cerebrospinal fluid: early response during bacterial meningitis. Journal of Infectious Diseases 1982, 145: 635–646.

    PubMed  Google Scholar 

  6. Barling, R. W. A., Selkon, J. B.: The penetration of antibiotics into cerebrospinal fluid and brain tissue. Journal of Antimicrobial Chemotherapy 1978, 4: 203–227.

    Google Scholar 

  7. Richards, M. L., Prince, R. A., Kenaley, K. A., Johnson, J. A., LeFrock, J. L.: Antimicrobial penetration into cerebrospinal fluid. Drug Intelligence and Clinical Pharmacy 1981, 15: 341–368.

    Google Scholar 

  8. Täuber, M. G., Sande, M. A.: Pathogenesis of bacterial meningitis: contributions by experimental models in rabbits. Infection 1984, 12: S3-S8.

    Article  PubMed  Google Scholar 

  9. Täuber, M. G., Khayam-Bashi, H., Sande, M. A.: Effects of ampicillin and corticosteroids on brain water content, cerebrospinal fluid pressure, and cerebrospinal fluid lactate levels in experimental pneumococcal meningitis. Journal of Infectious Diseases 1985, 151: 528–534.

    PubMed  Google Scholar 

  10. Schaad, U. B., McCracken, G. H., Jr.: Pharmacologiec basis for antimicrobial therapy of neonatal meningitis. Helvetica Paediatrica Acta 1981, 365: 19–30.

    Google Scholar 

  11. McCabe, W. R.: Empiric therapy for bacterial meningitis. Reviews of Infectious Diseases 1983, 5: S74-S84.

    PubMed  Google Scholar 

  12. Schaad, U. B., McCracken, G. H., Jr., Look, C. A., Thomas, M. L.: Pharmacokinetics and bacteriologic efficacy of moxalactam, cefotaxime, cefoperazone, and rocephin in experimental bacterial meningitis. Journal of Infectious Diseases 1981, 143: 156–163.

    PubMed  Google Scholar 

  13. Kobelt, R., Schaad, U. B.: Prospektive Evaluation von Coagglutination und Latex-Agglutination in der Diagnostik der bakteriellen Meningitiden im Kindesalter. Schweizerische Medizinische Wochenschrift 1986,116: 431–440.

    PubMed  Google Scholar 

  14. Teele, D. W., Dashefsky, B., Rakusan, T., Klein, J. O.: Meningitis after lumbar puncture in children with bacteremia. New England Journal of Medicine 1981, 305: 1079–1081.

    PubMed  Google Scholar 

  15. Feldman, W. E., Ginsburg, C. M., McCracken, G. H., Jr., Allen, D., Ahmann, P., Graham, J., Graham, L.: Relation of concentrations ofHaemophilus influenzae type b in cerebrospinal fluid to late sequelae of patients with meningitis. Journal of Pediatrics 1982, 100: 209–212.

    PubMed  Google Scholar 

  16. Smith, A. L.: Antibiotic resistance in haemophilus influenzae. Pediatric Infectious Diseases 1983, 2: 352–355.

    Google Scholar 

  17. Tuazon, C. U., Shamsuddin, D., Miller, H.: Antibiotic susceptibility and synergy of clinical isolates ofListeria monocytogenes. Antimicrobial Agents and Chemotherapy 1982, 21: 525–527.

    PubMed  Google Scholar 

  18. Laferriere, C. I., Marks, M. I.: Chloramphenicol: properties and clinical use. Pediatric Infectious Disease 1982, 1: 257–264.

    PubMed  Google Scholar 

  19. Young, L. S.: Problems in determining the efficacy of aminoglycosides. Reviews of Infectious Diseases 1983, 5: S250-S257.

    Google Scholar 

  20. Dajani, A. S.: Antibiotic-resistant pneumococci. Pediatric Infectious Disease 1982, 1: 143–144.

    PubMed  Google Scholar 

  21. Neu, H. C.: The new beta-lactamase-stable cephalosporins. Annals of Internal Medicine 1982, 97: 408–419.

    PubMed  Google Scholar 

  22. Schaad, U. B.: The cephalosporin compounds in severe neonatal infection. European Journal of Pediatrics 1984, 141: 143–146.

    Article  PubMed  Google Scholar 

  23. Schaad, U. B., Krucko, J., Pfenninger, J.: An extended experience with cefuroxime therapy of childhood bacterial meningitis. Pediatric Infectious Disease 1984, 3: 410–416.

    PubMed  Google Scholar 

  24. Baumgartner, E. T., Augustine, A., Steele, R. W.: Bacterial meningitis in older neonates. American Journal of Diseases in Children 1983, 137: 1052–1054.

    Google Scholar 

  25. Martin, E.: Once-daily administration of ceftriaxone in the treatment of meningitis and other serious infections in children. European Journal of Clinical Microbiology 1983, 2: 509–515.

    Article  PubMed  Google Scholar 

  26. Schaad, U. B., Nelson, J. D., McCracken, G. H., Jr.: Recrudescence and relapse in bacterial meningitis of childhood. Pediatrics 1981, 67: 188–195.

    PubMed  Google Scholar 

  27. Lin, T.-Y., Nelson, J. D., McCracken, G. H., Jr.: Fever during treatment for bacterial meningitis. Pediatric Infectious Disease 1984, 3: 319–322.

    PubMed  Google Scholar 

  28. Klein, J. O.: The epidemiology of pneumococcal disease in infants and children. Reviews of Infectious Diseases 1981, 3: 246–253.

    PubMed  Google Scholar 

  29. Schaad, U. B.: Chemoprophylaxis for the prevention of bacterial meningitis. Infection 1984, 12: S65-S68.

    Article  PubMed  Google Scholar 

  30. Schaad, U. B.: Chemoprophylaxis of bacterial meningitis. Journal of Antimicrobial Chemotherapy 1985, 15: 131–133.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schaad, U.B. Treatment of bacterial meningitis. Eur. J, Clin. Microbiol. 5, 492–497 (1986). https://doi.org/10.1007/BF02017689

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02017689

Keywords

Navigation